日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effects of Tofogliflozin and Anagliptin Alone or in Combination on Glucose Metabolism and Atherosclerosis-Related Markers in Patients with Type 2 Diabetes Mellitus.

托格列净和阿格列汀单独或联合用药对 2 型糖尿病患者葡萄糖代谢和动脉粥样硬化相关标志物的影响

Nomura Shosaku, Shouzu Akira, Taniura Takehito, Okuda Yoshinori, Omoto Seitaro, Suzuki Masahiko, Ito Tomoki, Toyoda Nagaoki

Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study)

沙格雷酯、二十碳五烯酸和匹伐他汀对 2 型糖尿病患者闭塞性动脉粥样硬化相关生物标志物的影响(SAREPITASO 研究)

Nomura, Shosaku; Taniura, Takehito; Shouzu, Akira; Omoto, Seitaro; Suzuki, Masahiko; Okuda, Yoshinori; Ito, Tomoki

Effects of teneligliptin on PDMPs and PAI-1 in patients with diabetes on hemodialysis

替格列汀对接受血液透析的糖尿病患者PDMPs和PAI-1的影响

Okuda, Yoshinori; Omoto, Seitaro; Taniura, Takehito; Shouzu, Akira; Nomura, Shosaku

Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus.

西格列汀对 2 型糖尿病患者的抗动脉粥样硬化作用

Omoto Seitaro, Taniura Takehito, Nishizawa Tohru, Tamaki Takeshi, Shouzu Akira, Nomura Shosaku

Effects of pitavastatin on plasminogen activator inhibitor-1 in hyperlipidemic patients

匹伐他汀对高脂血症患者纤溶酶原激活物抑制剂-1的影响

Nomura, Shosaku; Taniura, Takehito; Shouzu, Akira; Omoto, Seitarou; Inami, Norihito; Fujita, Shinya; Tamaki, Takeshi; Yokoi, Takashi; Shimizu, Toshiki; Ito, Tomoki

Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus

米格列醇对2型糖尿病患者血小板衍生微粒、脂联素和选择素水平的影响

Nomura, Shosaku; Omoto, Seitaro; Yokoi, Takashi; Fujita, Shinya; Ozasa, Ryotaro; Eguchi, Noritaka; Shouzu, Akira